[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1563 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. R. 1563
To amend the Controlled Substances Act to clarify that the possession,
sale, purchase, importation, exportation, or transportation of drug
testing equipment that tests for the presence of fentanyl or xylazine
is not unlawful.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 25, 2025
Ms. Crockett (for herself and Mr. Gooden) introduced the following
bill; which was referred to the Committee on the Judiciary, and in
addition to the Committee on Energy and Commerce, for a period to be
subsequently determined by the Speaker, in each case for consideration
of such provisions as fall within the jurisdiction of the committee
concerned
_______________________________________________________________________
A BILL
To amend the Controlled Substances Act to clarify that the possession,
sale, purchase, importation, exportation, or transportation of drug
testing equipment that tests for the presence of fentanyl or xylazine
is not unlawful.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Safeguarding Testing and Overdose
Prevention Against Fentanyl and Xylazine Act'' or the ``STOP Fentanyl
and Xylazine Act''.
SEC. 2. CLARIFICATION REGARDING THE TREATMENT OF EQUIPMENT THAT
INDICATES THE PRESENCE OF FENTANYL OR XYLAZINE IN A
COMPOUND.
Section 422 of the Controlled Substances Act (21 U.S.C. 863) is
amended by adding at the end the following:
``(g) Clarification.--This section does not apply to the
possession, sale, purchase, importation, exportation, or transportation
of equipment for which the intended use is to indicate the presence of
fentanyl or xylazine in a compound.''.
<all>